08/15/2024
5:31 PM | Lyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
07/23/2024
3:05 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:15 PM | Lyra Therapeutics (Filer)
| Form 8-K/A | |
05/21/2024
8:15 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
3:15 PM | Lyra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:36 PM | Lyra Therapeutics (Filer)
| Form DEFA14A | |
04/19/2024
3:17 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:20 PM | Lyra Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
11:15 PM | Lyra Therapeutics (Filer)
| Form EFFECT | |
03/22/2024
6:38 AM | Lyra Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
6:41 AM | Lyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/22/2024
5:58 AM | Lyra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
6:20 PM | Lyra Therapeutics (Issuer)
Palasis Maria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
6:21 PM | Lyra Therapeutics (Issuer)
Waksal Harlan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
8:18 AM | Lyra Therapeutics (Subject)
PURA VIDA INVESTMENTS, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
7:35 PM | Lyra Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
5:18 PM | CITADEL ADVISORS LLC (Filed by)
Lyra Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
5:13 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
5:40 AM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:16 PM | Lyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
4:00 PM | Lyra Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
11/13/2023
4:29 PM | Lyra Therapeutics (Issuer)
Waksal Harlan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
3:23 PM | Lyra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
